Cargando…
TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061958/ http://dx.doi.org/10.1186/ar2258 |
_version_ | 1782321580472270848 |
---|---|
author | Burge, DJ Shu, C Martin, RW Littlejohn, TW Wallace, DJ Taborn, J Palmer, WR Kivitz, A |
author_facet | Burge, DJ Shu, C Martin, RW Littlejohn, TW Wallace, DJ Taborn, J Palmer, WR Kivitz, A |
author_sort | Burge, DJ |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4061958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40619582014-06-19 TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis Burge, DJ Shu, C Martin, RW Littlejohn, TW Wallace, DJ Taborn, J Palmer, WR Kivitz, A Arthritis Res Ther Poster Presentation BioMed Central 2007 2007-10-19 /pmc/articles/PMC4061958/ http://dx.doi.org/10.1186/ar2258 Text en Copyright © 2007 BioMed Central Ltd |
spellingShingle | Poster Presentation Burge, DJ Shu, C Martin, RW Littlejohn, TW Wallace, DJ Taborn, J Palmer, WR Kivitz, A TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title | TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title_full | TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title_fullStr | TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title_full_unstemmed | TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title_short | TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
title_sort | tru-015, a small modular immunopharmaceutical (smip™) drug candidate directed against cd20, demonstrates clinical improvement in subjects with rheumatoid arthritis |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061958/ http://dx.doi.org/10.1186/ar2258 |
work_keys_str_mv | AT burgedj tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT shuc tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT martinrw tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT littlejohntw tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT wallacedj tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT tabornj tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT palmerwr tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis AT kivitza tru015asmallmodularimmunopharmaceuticalsmipdrugcandidatedirectedagainstcd20demonstratesclinicalimprovementinsubjectswithrheumatoidarthritis |